Immunolocalization of CD1d in human intestinal epithelial cells and identification of a

K Somnay-Wadgaonkar1, A Nusrat, H S Kim

  • 1Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

Insights

Researchers identified CD1d glycoproteins on human intestinal epithelial cells, localizing them to apical and lateral surfaces. This strategic positioning suggests a role in sampling luminal antigens for immune presentation.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • CD1d molecules present lipid antigens to T cells.
  • Understanding CD1d's role in the intestine is crucial for mucosal immunity.

Purpose of the Study:

  • To define the cellular localization and biochemical structure of CD1d in human intestinal epithelial cells (IEC).

Main Methods:

  • Immunoprecipitation and Western blotting using CD1d-specific antibodies.
  • N-glycanase digestion to analyze protein glycosylation.
  • Confocal laser microscopy for immunolocalization.
  • Selective cell surface biotinylation.

Main Results:

  • Identified a 37 kDa non-glycosylated and a 48-50 kDa beta2-microglobulin-associated CD1d glycoprotein in IEC.
  • Demonstrated CD1d localization to both apical and lateral surfaces of intestinal epithelial cells.
  • Revealed a significant intracellular apical pool of CD1d.
  • Confirmed glycosylated CD1d on both apical and basolateral surfaces, with the non-glycosylated form on the apical surface.

Conclusions:

  • CD1d is strategically localized on intestinal epithelial cells for luminal antigen sampling.
  • The identified CD1d forms and locations support its role in presenting antigens to intraepithelial lymphocytes.